Academic committee of Japan Society for Endoscopic Surgery, Tokyo, Japan.
Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine, Yufu, Japan.
Asian J Endosc Surg. 2024 Apr;17(2):e13285. doi: 10.1111/ases.13285.
This article reports the results of the 16th National Survey conducted by the Japan Society for Endoscopic Surgery (JSES) for 2020 and 2021. Laparoscopic cholecystectomy was first introduced to Japan in 1990 and has rapidly become popular because of its minimally invasive nature. Since then, the number of objective organs and indications for laparoscopic surgery have gradually expanded. In 2021, 290 787 patients underwent endoscopic surgery in all surgical domains. Of these, 124 614, 110 757, 23 156, 21 771, 6543, 2614, 535, 465, 247, and 58 underwent abdominal, obstetric and gynecologic, thoracic, urological, pediatric, orthopedic, bariatric, mammary and thyroid gland, cardiovascular, and plastic surgery, respectively. Owing to the impact of the coronavirus disease 2019 (COVID-19) infection spread, the incidence of many surgeries decreased in 2020, and levels are only now gradually recovering. However, despite the impact of COVID-19, robot-assisted surgeries were increasingly applied. The rate of complications did not change significantly, indicating that the procedure was performed safely, even with the spread of COVID-19.
本文报道了日本内镜外科学会（JSES）于 2020 年至 2021 年进行的第 16 次全国调查结果。腹腔镜胆囊切除术于 1990 年首次引入日本，因其微创性而迅速普及。此后，腹腔镜手术的客观器官和适应证逐渐扩大。2021 年，所有外科领域共有 290787 例内镜手术。其中，124614 例、110757 例、23156 例、21771 例、6543 例、2614 例、535 例、465 例、247 例和 58 例分别接受了腹部、妇产科、胸科、泌尿科、儿科、骨科、减重、乳腺和甲状腺、心血管和整形外科手术。由于 2019 年冠状病毒病（COVID-19）感染传播的影响，许多手术的发病率在 2020 年下降，目前水平正在逐渐恢复。然而，尽管受到 COVID-19 的影响，机器人辅助手术的应用越来越多。并发症发生率没有明显变化，表明即使 COVID-19 传播，手术也安全进行。
